Regarding the regulation of gastric acid secretion, all of the following statements are correct EXCEPT:

Explanation

## Regulation of Gastric Acid Secretion — Correcting the Misconception ### The Three Correct Statements **Key Point:** Gastric acid secretion is regulated by three main stimulants (histamine, gastrin, acetylcholine) and one major inhibitor (somatostatin). | Regulator | Receptor Type | Location | Effect on Acid | |-----------|---------------|----------|----------------| | Histamine | H2 | Parietal cell | ↑ via cAMP pathway | | Gastrin | CCK-B | Parietal cell | ↑ synergistic with histamine | | Acetylcholine | **M3** | Parietal cell | ↑ via IP3/DAG pathway | | Somatostatin | SSTR | G-cell, ECL cell, Parietal cell | ↓ (inhibition) | **Option A (Correct):** Histamine is released by enterochromaffin-like (ECL) cells and acts on H2 receptors on parietal cells. This increases intracellular cAMP, activating protein kinase A and ultimately increasing H⁺ secretion via the H⁺/K⁺-ATPase pump. **Option B (Correct):** Gastrin (released by G-cells in response to amino acids, peptides, and gastric distension) binds CCK-B receptors on parietal cells. Gastrin and histamine work synergistically — neither alone produces maximal acid secretion. **Option C (Correct):** Somatostatin inhibits acid secretion through multiple mechanisms — it acts on SSTR receptors on G-cells to inhibit gastrin release, on ECL cells to inhibit histamine release, and SSTR2 receptors have also been identified on parietal cells. The net effect is inhibition of acid secretion. This statement is therefore correct. ### The Incorrect Statement (Option D) **Warning:** This is the trap. Acetylcholine from vagal parasympathetic nerve endings does NOT act on **M1** receptors on parietal cells. The correct receptor subtype on parietal cells is **M3 (muscarinic-3)**. M1 receptors are located on ECL cells and intramural neurons, where they stimulate histamine release and modulate neural transmission, respectively. - **M3 receptors** on parietal cells → activated by acetylcholine → phospholipase C pathway (IP3/DAG) → ↑ intracellular Ca²⁺ → acid secretion - **M1 receptors** on ECL cells → stimulate histamine release (indirect stimulation of parietal cells) This distinction is well-established in Ganong's Review of Medical Physiology and KD Tripathi's Essentials of Medical Pharmacology. **High-Yield:** The three direct stimulants of parietal cell acid secretion are histamine (H2), gastrin (CCK-B), and acetylcholine (**M3**). Pirenzepine, a selective M1 antagonist, reduces acid secretion primarily by blocking M1 receptors on ECL cells and neurons — NOT by blocking M3 on parietal cells. **Mnemonic:** Parietal cell receptors = **H2, CCK-B, M3** (not M1). ### Clinical Pearl Proton pump inhibitors (omeprazole, lansoprazole) block the final common pathway (H⁺/K⁺-ATPase), making them effective regardless of which stimulant is driving acid secretion. H2 blockers (ranitidine, famotidine) only block histamine's pathway. Pirenzepine (M1 antagonist) reduces acid secretion indirectly via ECL cells and neurons, not by direct M3 blockade on parietal cells.